Review of Herbal Traditional Chinese Medicine for the Treatment of Diabetic Nephropathy

Journal of Diabetes Research

Volumn 2016, Issue , 2016, Pages

  Sun, Guang Dong ^a   Li, Chao Yuan ^a   Cui, Wen Peng ^a   Guo, Qiao Yan ^a   Dong, Chang Qing ^a   Zou, Hong Bin ^a   Liu, Shu Jun ^a   Dong, Wen Peng ^a   Miao, Li Ning ^a  

^a THE SECOND HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ASTRAGALUS ROOT; BERBERINE; CHAIHUANG YISHEN; CHINESE DRUG; COMPOUND RHIZOMA COPTIDIS CAPSULE; CURCUMIN; DANGGUI SHAOYAO SAN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUFANG XUE SHUAN TONG; GENIPIN; GIZHI JIANGTANG; HACHIMIJIOGAN; HU LU BA WAN; ORYEONGSAN; PROTECTIVE AGENT; QIWEI GRANULE; SHENHUA; SHENKANGWAN; TANGSHEN FORMULA; TONGSHENLUO; TONGXINLUO; UNCLASSIFIED DRUG; UNINDEXED DRUG; XIANZHEN; XIAO CHAI HU TANG; XIAOKE GRANULE; XIEXIN DECOCTION; ZAO HUANG; ZHENQING; ZISHENTONGLUO; HERBACEOUS AGENT;

ANGELICA SINENSIS; BUPLEURUM; CARABIDAE; CENTIPEDE; CHINESE MEDICINE; CURCUMA LONGA; CURCUMA ZEDOARIA; CUSCUTA; DIABETIC NEPHROPATHY; EARTHWORM; EPIMEDIUM; GINSENG; HERBAL MEDICINE; HIRUDO; HOUTTUYNIA CORDATA; HUMAN; KIDNEY FUNCTION; LEECH; LOQUAT; NONHUMAN; OXIDATIVE STRESS; PANAX NOTOGINSENG; POLYPORUS UMBELLATUS; PORIA COCOS; PRIORITY JOURNAL; PUERARIA; REHMANNIA; RENAL PROTECTION; REVIEW; SAFFLOWER; SALVIA MILTIORRHIZA; SARGASSUM; SCHISANDRA; SCUTELLARIA; TALUS; WESTERN MEDICINE; YAM; DIABETIC NEPHROPATHIES; PHYTOTHERAPY; TREATMENT OUTCOME;

DIABETIC NEPHROPATHIES; DRUGS, CHINESE HERBAL; HUMANS; MEDICINE, CHINESE TRADITIONAL; PHYTOTHERAPY; TREATMENT OUTCOME;

EID: 84948783618     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2016/5749857     Document Type: Review

References (129)

1. T. Scully, "Diabetes in numbers," Nature, vol. 485, no. 7398, pp. 52-53, 2012.
2. E. Vivian and C. Mannebach, "Therapeutic approaches to slowing the progression of diabetic nephropathy-is less best?" Drugs in Context, vol. 2013, Article ID 212249, 2013.
3. R. J. Macisaac, E. I. Ekinci, and G. Jerums, "Markers of and risk factors for the development and progression of diabetic kidney disease," American Journal of Kidney Diseases, vol. 63, no. 2, pp. S39-S62, 2014.
4. J. Skupien, J. H. Warram, A. M. Smiles et al., "The early decline in renal function in patients with type 1 diabetes and proteinuria predicts the risk of end-stage renal disease," Kidney International, vol. 82, no. 5, pp. 589-597, 2012.
5. Y. S. Kanwar, L. Sun, P. Xie, F.-Y. Liu, and S. Chen, "A glimpse of various pathogenetic mechanisms of diabetic nephropathy," Annual Review of Pathology: Mechanisms of Disease, vol. 6, pp. 395-423, 2011.
6. M. A. Reddy, J. Tak Park, and R. Natarajan, "Epigenetic modifications in the pathogenesis of diabetic nephropathy," Seminars in Nephrology, vol. 33, no. 4, pp. 341-353, 2013.
7. S. O. Kolset, F. P. Reinholt, and T. Jenssen, "Diabetic nephropathy and extracellular matrix," The Journal of Histochemistry and Cytochemistry, vol. 60, no. 12, pp. 976-986, 2012.
8. G. D. Sun, W. P. Cui, Q. Y. Guo, and L. N. Miao, "Histone lysine methylation in diabetic nephropathy," Journal of Diabetes Research, vol. 2014, Article ID 654148, 9 pages, 2014.
9. A. P. Sanchez and K. Sharma, "Transcription factors in the pathogenesis of diabetic nephropathy," Expert Reviews in Molecular Medicine, vol. 11, article e13, 2009.
10. A. K. H. Lim, "Diabetic nephropathy-complications and treatment," International Journal of Nephrology and Renovascular Disease, vol. 7, pp. 361-381, 2014.
11. H. J. L. Heerspink and D. de Zeeuw, "The kidney in type 2 diabetes therapy," Review of Diabetic Studies, vol. 8, no. 3, pp. 392-402, 2011.
12. H. Yamout, I. Lazich, and G. L. Bakris, "Blood pressure, hypertension, RAAS blockade, and drug therapy in diabetic kidney disease," Advances in Chronic Kidney Disease, vol. 21, no. 3, pp. 281-286, 2014.
13. L. F. Fried, N. Emanuele, J. H. Zhang et al., "Combined angiotensin inhibition for the treatment of diabetic nephropathy," The New England Journal of Medicine, vol. 369, no. 20, pp. 1892-1903, 2013.
14. X.-L. Tong, L. Dong, L. Chen, and Z. Zhen, "Treatment of diabetes using traditional Chinese medicine: past, present and future," The American Journal of Chinese Medicine, vol. 40, no. 5, pp. 877-886, 2012.
15. X. Shi, X. G. Lu, L. B. Zhan et al., "The effects of the Chinese medicine ZiBu PiYin recipe on the hippocampus in a rat model of diabetes-associated cognitive decline: a proteomic analysis," Diabetologia, vol. 54, no. 7, pp. 1888-1899, 2011.
16. H.-L. Zhao, Y. Sui, C.-F. Qiao et al., "Sustained antidiabetic effects of a berberine-containing Chinese herbal medicine through regulation of hepatic gene expression," Diabetes, vol. 61, no. 4, pp. 933-943, 2012.
17. X. Wen, Y. Zeng, L. Liu et al., "Zhenqing recipe alleviates diabetic nephropathy in experimental type 2 diabetic rats through suppression of SREBP-1c," Journal of Ethnopharmacology, vol. 142, no. 1, pp. 144-150, 2012.
18. R. Teschke, A. Wolff, C. Frenzel, A. Eickhoff, and J. Schulze, "Herbal traditional Chinese medicine and its evidence base in gastrointestinal disorders," World Journal of Gastroenterology, vol. 21, no. 15, pp. 4466-4490, 2015.
19. G. Wang, B. Mao, Z.-Y. Xiong et al., "The quality of reporting of randomized controlled trials of traditional Chinesemedicine: a survey of 13 randomly selected journals from mainland China," Clinical Therapeutics, vol. 29, no. 7, pp. 1456-1467, 2007.
20. T. T. Zhao, H. J. Zhang, X. G. Lu et al., "Chaihuang-Yishen granule inhibits diabetic kidney disease in rats through blocking TGF-β/Smad3 signaling," PLoS ONE, vol. 9, no. 3, Article ID e90807, 2014.
21. S. Liu, L.-Q. Tang, L.-M. Chen, X.-Q. Chen, S.-T. Zhang, and Y. Wei, "Effect of compound Rhizoma Coptidis capsule on expression of transforming growth factor-β1 and type IV collagen proteins in renal tissue of diabetic rats with nephropathy," Zhongguo zhongyao zazhi, vol. 33, no. 1, pp. 68-72, 2008.
22. W.-J. Geng, R.-B. Wei, and W. Mao, "Protective effects of compound shenhua tablet on diabetic nephropathy rats," Zhongguo Zhongxiyi Jiehe Zazhi, vol. 32, no. 3, pp. 352-355, 2012.
23. 1 gene expression by danggui buxue tang, a traditional Chinese herbal preparation, in retarding the progress of renal damage in streptozotocin-induced diabetic rats," Hormone and Metabolic Research, vol. 38, no. 2, pp. 82-88, 2006.
24. H.-L. Ke, Y.-W. Zhang, B.-F. Zhou, and R.-T. Zhen, "Effects of Danggui Buxue Tang, a traditional Chinese herbal decoction, on high glucose-induced proliferation and expression of extracellular matrix proteins in glomerular mesangial cells," Natural Product Research, vol. 26, no. 11, pp. 1022-1026, 2012.
25. I.-M. Liu, T.-F. Tzeng, S.-S. Liou, and C. J. Chang, "Beneficial effect of traditional chinese medicinal formula Danggui-Shaoyao-San on advanced glycation end-product-mediated renal injury in streptozotocin-diabetic rats," Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 140103, 10 pages, 2012.
26. D. Fang, X. Wan, W. Deng et al., "Fufang Xue Shuan tong capsules inhibit renal oxidative stress markers and indices of nephropathy in diabetic rats," Experimental and Therapeutic Medicine, vol. 4, no. 5, pp. 871-876, 2012.
27. T. Yokozawa, N. Yamabe, E. J. Cho, T. Nakagawa, and S. Oowada, "A study on the effects to diabetic nephropathy of hachimi-jiogan in rats," Nephron Experimental Nephrology, vol. 97, no. 2, pp. e38-e48, 2004.
28. C. Kiga, T. Nakagawa, K. Koizumi et al., "Expression patterns of plasma proteins in spontaneously diabetic rats after oral administration of a Kampo medicine, Hachimi-jio-gan, using SELDI Protein Chip platform," Biological & Pharmaceutical Bulletin, vol. 28, no. 6, pp. 1031-1037, 2005.
29. T. Nakagawa, T. Yokozawa, N. Yamabe et al., "Long-term treatment with Hachimi-jio-gan attenuates kidney damage in spontaneously diabetic WBN/Kob rats," Journal of Pharmacy and Pharmacology, vol. 57, no. 9, pp. 1205-1212, 2005.
30. N. Yamabe and T. Yokozawa, "Activity of the Chinese prescription Hachimi-jio-gan against renal damage in the Otsuka Long-Evans Tokushima fatty rat: a model of human type 2 diabetes mellitus," The Journal of Pharmacy and Pharmacology, vol. 58, no. 4, pp. 535-545, 2006.
31. L. Zhou, H. Dong, Y. Huang et al., "Hu-Lu-Ba-Wan attenuates diabetic nephropathy in type 2 diabetic rats through PKC-α/NADPH oxidase signaling pathway," Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 504642, 10 pages, 2013.
32. X.-Y. Song, Q. Chen, and X.-Y. Qi, "Effect of liuwei dihuang pill on erythrocyte aldose reductase activity in early diabetic nephropathy patients," Zhongguo Zhongxiyi Jiehe Zazhi, vol. 24, no. 12, pp. 1087-1090, 2004.
33. P.-C. Hsu, Y.-T. Tsai, J.-N. Lai, C.-T. Wu, S.-K. Lin, and C.-Y. Huang, "Integrating traditional Chinese medicine healthcare into diabetes care by reducing the risk of developing kidney failure among type 2 diabetic patients: a population-based case control study," Journal of Ethnopharmacology, vol. 156, pp. 358-364, 2014.
34. I.-M. Liu, T.-F. Tzeng, S.-S. Liou, and C. J. Chang, "The amelioration of streptozotocin diabetes-induced renal damage by Wu-Ling-San (Hoelen Five Herb Formula), a traditional Chinese prescription," Journal of Ethnopharmacology, vol. 124, no. 2, pp. 211-218, 2009.
35. J. J. Yoon, Y. J. Lee, D. G. Kang, and H. S. Lee, "Protective role of oryeongsan against renal inflammation and glomerulosclerosis in db/db mice," The American Journal of Chinese Medicine, vol. 42, no. 6, pp. 1431-1452, 2014.
36. Z. A. Guo, C. J. Yu, G. Liu, F. C. Meng, Y. Li, and S. L. Peng, "Treatment of stage 3b diabetic kidney disease patients with macroalbuminuria by Qizhi Jiangtang capsule: a multicenter randomized control clinical study," Zhongguo Zhongxiyi Jiehe Zazhi, vol. 34, no. 9, pp. 1047-1052, 2014.
37. M.-Z. Li, Y.-B. Gao, and M.-F. Ma, "Effects of qiwei granule on the protein andm RNA expressions of renal tissue transforming growth factor-beta1 in KK-Ay mice with spontaneous type 2 diabetes mellitus," Zhongguo Zhongxiyi jiehe zazhi, vol. 32, no. 12, pp. 1675-1678, 2012.
38. G.-B. Chen, L.-B. Wei, W. Xiao, and H.-B. Long, "Effect of Shenkangwan on mesangial cell NO and TGF-beta1 excretion in rats with early diabetic nephropathy," Journal of Southern Medical University, vol. 26, no. 4, pp. 526-528, 2006.
39. H.-B. Long, H.-X. Niu, X.-Y. Li et al., "Effects of Shenkangwan on renal expressions of angiotensin II and its type I receptor in rats with early diabetic nephropathy," Journal of Southern Medical University, vol. 30, no. 4, pp. 805-809, 2010.
40. J.-J. Yin, Y. Yang, Q.-B. Wang, Y. Li, and D.-K. Yin, "Effect of Chinese herbal medicine with Supplement Qi and Activating Blood Circulation on tubular reabsorption function of diabetic nephropathy rats," Journal of Chinese medicinal materials, vol. 36, no. 6, pp. 953-958, 2013.
41. D.-K. Yin, Y. Yang, and Y. Li, "Effect of supplementing Qi and activating blood circulationmethod on protein uptake in NRK-52E cells injured by high glucose," Journal of Chinese Medicinal Materials, vol. 37, no. 1, pp. 91-94, 2014.
42. M. Huang, C. Zhu, Q.-L. Liang et al., "Effect of Tangshen formula on phospholipids metabolism in diabetic nephropathy patients," Acta Pharmaceutica Sinica, vol. 46, no. 7, pp. 780-786, 2011.
43. Z.-T. Jiang, Q.-L. Liang, and Y.-M. Wang, "Effects of tangshen recipe on the homocysteine metabolism of patients with diabetic nephropathy," Zhongguo Zhongxiyi jiehe zazhi, vol. 31, no. 8, pp. 1057-1061, 2011.
44. J. Hu, X. Fan, X. Meng, Y. Wang, Q. Liang, and G. Luo, "Evidence for the involvement of JAK/STAT/SOCS pathway in the mechanism of Tangshen formula-treated diabetic nephropathy," Planta Medica, vol. 80, no. 8-9, pp. 614-621, 2014.
45. Y.-L. Wu, C. Wei, and H.-T. Wang, "Effect of tongshenluo capsule on the components of extracellular matrix and their metabolism in kidney of rats with diabetic nephropathy," Zhongguo Zhongxiyi Jiehe Zazhi, vol. 27, no. 4, pp. 326-330,2007.
46. Y. Zhao and X.-L. Zhang, "Effect of tongxinluo capsule on plasma endothelin in patients with diabetic nephropathy," Zhongguo Zhongxiyi Jiehe Zazhi, vol. 25, no. 2, pp. 131-133, 2005.
47. J.-Y. Wang, Y.-B. Gao, N. Zhang et al., "Tongxinluo ameliorates renal structure and function by regulating mir-21-induced epithelial-to-mesenchymal transition in diabetic nephropathy," The American Journal of Physiology-Renal Physiology, vol. 306, no. 5, pp. F486-F495, 2014.
48. C.-C. Lin, L.-T. Lin, M.-H. Yen, J.-T. Cheng, C.-H. Hsing, and C.-H. Yeh, "Renal protective effect of Xiao-Chai-Hu-Tang on diabetic nephropathy of type 1-diabetic mice," Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 984024, 11 pages, 2012.
49. X.-M. Ji, Q. Wang, and F. Qi, "Effect of xiaoke granule on blood glucose, urinary protein and glomerular morphology in rats with diabetic nephropathy," Zhongguo Zhongxiyi Jiehe Zazhi, vol. 24, no. 6, pp. 534-537, 2004.
50. X.-M. Ji, Q. Wang, M.-X. Gong, Y.-Q. Du, and D.-X. Jia, "Effects of Xiaoke granule on transforming growth factor-beta1, expression and proliferation in rat mesangial cells," Chinese Medical Journal, vol. 119, no. 21, pp. 1839-1842, 2006.
51. J.-S. Wu, R. Shi, J. Zhong et al., "Renal protective role of Xiexin decoction with multiple active ingredients involves inhibition of inflammation through downregulation of the nuclear factor-κB pathway in diabetic rats," Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID715671, 15 pages, 2013.
52. J. S. Wu, R. Shi, X. Lu, Y.M. Ma, and N.N. Cheng, "Combination of active components of xiexin decoction ameliorates renal fibrosis through the inhibition of NF-κB and TGF-β1/smad pathways in db/db diabetic mice," PLoS ONE, vol. 10, no. 3, Article ID e0122661, 2015.
53. D.-Y. Tang, S.-S. Guo, and R.-Y. Sun, "Effect of xianzhen tablet on content of advanced glycosylation end products (AGEs) and mRNA expression of AGE-specific cellular receptor in renal cortex of diabetic rats," Zhongguo Zhongxiyi jiehe zazhi, vol. 25, no. 1, pp. 60-63, 2005.
54. L. Zhao, H. Gao, Y. Zhao, and D. Lin, "Metabonomic analysis of the therapeutic effect of Zhibai Dihuang Pill in treatment of streptozotocin-induced diabetic nephropathy," Journal of Ethnopharmacology, vol. 142, no. 3, pp. 647-656, 2012.
55. J.W. Ju, S. H. Mu, Y. Z. Yin, C.K. Lu, X. Y. Sun, and L. X. Deng, "Effects of zao huang mixture (see text) on the expressions of TGF-beta1 and Col IV in human glomerular mesangial cells cultured in high glucose environment," Journal of Traditional Chinese Medicine, vol. 31, no. 2, pp. 127-129, 2011.
56. J. Ma, L. Xu, J. Dong et al., "Effects of zishentongluo in patients with early-stage diabetic nephropathy," The American Journal of Chinese Medicine, vol. 41, no. 2, pp. 333-340, 2013.
57. H. He, X. Yang, X. Zeng et al., "Protective effect of Liuwei Dihuang decoction on early diabetic nephropathy induced by streptozotocin via modulating ET-ROS axis and matrix metalloproteinase activity in rats," The Journal of Pharmacy and Pharmacology, vol. 59, no. 9, pp. 1297-1305, 2007.
58. H.-R. Liu, X.-Y. Tang, D.-Z. Dai, and Y. Dai, "Ethanol extracts of Rehmannia complex (Di Huang) containing no Corni fructus improve early diabetic nephropathy by combining suppression on the ET-ROS axis withmodulate hypoglycemic effect in rats," Journal of Ethnopharmacology, vol. 118, no. 3, pp. 466-472, 2008.
59. W. Xiao, L.-B. Wei, Y. Ma, H.-B. Long, and G.-B. Chen, "Renal protective effect of Shenkang pill on diabetic rats," Zhongguo zhongyao zazhi, vol. 31, no. 12, pp. 1006-1009, 2006.
60. W. Xiao, Y. Ma, and L.-B. Wei, "Effect of shenkangwan on TGFbeta1 and FN in rat mesangial cells cultured by high glucose," Journal of Chinese Medicinal Materials, vol. 29, no. 9, pp. 924-927, 2006.
61. H.-B. Long, H. Zhang, J. Zhong, Y. Zhu, J.-H. He, and L.-B. Wei, "Protective effects of Shenkangwan against podocyte injury in rats with early diabetic nephropathy," Journal of Southern Medical University, vol. 28, no. 7, pp. 1268-1272, 2008.
62. N. Zhang, Y. Gao, D. Zou et al., "Effects of Chinese medicine Tong xinluo on diabetic nephropathy via inhibiting TGF-β1-induced epithelial-to-mesenchymal transition," Evidence-Based Complementary and Alternative Medicine, vol. 2014, Article ID 123497, 12 pages, 2014.
63. M. Li, W. Wang, J. Xue, Y. Gu, and S. Lin, "Meta-analysis of the clinical value of Astragalus membranaceus in diabetic nephropathy," Journal of Ethnopharmacology, vol. 133, no. 2, pp. 412-419, 2011.
64. Y. Nie, S. Li, Y. Yi et al., "Effects of astragalus injection on the TGFβ/Smad pathway in the kidney in type 2 diabetic mice," BMC Complementary and Alternative Medicine, vol. 14, article 148, 2014.
65. S. Mou, Z.-H. Ni, and Q.-Y. Zhang, "Expression of c-met in human kidney fibroblasts induced by high glucose in vitro and the regulation of Radix Astragali," Journal of Chinese Integrative Medicine, vol. 6, no. 5, pp. 482-487, 2008.
66. F. L. Wang, L. Q. Tang, F. Yang, L. N. Zhu, M. Cai, and W. Wei, "Renoprotective effects of berberine and its possible molecularmechanisms in combination of high-fat diet and lowdose streptozotocin-induced diabetic rats," Molecular Biology Reports, vol. 40, no. 3, pp. 2405-2418, 2013.
67. M. Lu, L. Tao, W. Mei et al., "Effect of curcumin on the expression of p-STAT3 and IκB in db/db mice," Journal of Central South University (Medical Sciences), vol. 39, no. 6, pp. 591-597, 2014.
68. J.-P. Liu, L. Feng, M.-M. Zhu et al., "The in vitro protective effects of curcumin and demethoxycurcumin in Curcuma longa extract on advanced glycation end products-inducedmesangial cell apoptosis and oxidative stress," Planta Medica, vol. 78, no. 16, pp. 1757-1760, 2012.
69. N. Zheng, X. Lin, Q. Wen et al., "Effect of 2-dodecyl-6-methoxycyclohexa-2,5-diene-1,4-dione, isolated from Averrhoa carambola L. (Oxalidaceae) roots, on advanced glycation endproduct-mediated renal injury in type 2 diabetic KKAy mice," Toxicology Letters, vol. 219, no. 1, pp. 77-84, 2013.
70. Y. Xie, Q. Wang, J. Liu, J. Xie, K. Xue, and Q. Tang, "Dracorhodin perchlorate inhibit high glucose induce serum and glucocorticoid induced protein kinase 1 and fibronectin expression in human mesangial cells," Zhongguo Zhongyao Zazhi, vol. 35, no. 15, pp. 1996-2000, 2010.
71. H.-W. Zhu, Z.-F. Shi, and Y.-Y. Chen, "Effect of extract of ginkgo bilboa leaf on early diabetic nephropathy," Zhongguo Zhongxiyi jiehe zazhi, vol. 25, no. 10, pp. 889-891, 2005.
72. X.-S. Li, X.-J. Fu, and X.-J. Lang, "Effect of extract of Gingko biloba on soluble intercellular adhesion molecule-1 and soluble vascular cell adhesionmolecule-1 in patients with early diabetic nephropathy," Zhongguo Zhongxiyi Jiehe Zazhi, vol. 27, no. 5, pp. 412-414, 2007.
73. J.-Y. Wang, X.-X. Yin, Y.-M. Wu et al., "Ginkgo biloba extract suppresses hypertrophy and extracellular matrix accumulation in rat mesangial cells," Acta Pharmacologica Sinica, vol. 27, no. 9, pp. 1222-1230, 2006.
74. A. Fujita, H. Sasaki, A. Doi et al., "Ferulic acid prevents pathological and functional abnormalities of the kidney in Otsuka Long-Evans Tokushima Fatty diabetic rats," Diabetes Research and Clinical Practice, vol. 79, no. 1, pp. 11-17, 2008.
75. R. Choi, B. H. Kim, J. Naowaboot et al., "Effects of ferulic acid on diabetic nephropathy in a rat model of type 2 diabetes," Experimental & Molecular Medicine, vol. 43, no. 12, pp. 676-683, 2011.
76. L. Zhou, X.-F. An, S.-C. Teng et al., "Pretreatment with the total flavone glycosides of Flos Abelmoschus manihot and hyperoside prevents glomerular podocyte apoptosis in streptozotocin-induced diabetic nephropathy," Journal of Medicinal Food, vol. 15, no. 5, pp. 461-468, 2012.
77. W. Qiu, Y. Zhou, L. Jiang et al., "Genipin inhibits mitochondrial uncoupling protein 2 expression and ameliorates podocyte injury in diabetic mice," PLoS ONE, vol. 7, no. 7, Article ID e41391, 2012.
78. 1 in the renal tissues of diabetic rats," Journal of Traditional Chinese Medicine, vol. 27, no. 3, pp. 220-225, 2007.
79. 1 and type IV collagen expression in rats," Journal of Ethnopharmacology, vol. 138, no. 3, pp. 731-736, 2011.
80. G. T. Lee, H. Ha, M. Jung et al., "Delayed treatment with lithospermate B attenuates experimental diabetic renal injury," Journal of the American Society of Nephrology, vol. 14, no. 3, pp. 709-720, 2003.
81. K. Y. Hur, S. H. Kim, M.-A. Choi et al., "Protective effects of magnesium lithospermate B against diabetic atherosclerosis via Nrf2-ARE-NQO1 transcriptional pathway," Atherosclerosis, vol. 211, no. 1, pp. 69-76, 2010.
82. R. Zhao, Q.-W. Li, J. Li, and T. Zhang, "Protective effect of Lycium barbarum polysaccharide 4 on kidneys in streptozotocin-induced diabetic rats," Canadian Journal of Physiology and Pharmacology, vol. 87, no. 9, pp. 711-719, 2009.
83. Q. Wen, T. Liang, F. Qin et al., "Lyoniresinol 3α-O-β-Dglucopyranoside-mediated hypoglycaemia and its influence on apoptosis-regulatory protein expression in the injured kidneys of streptozotocin-induced mice," PLoS ONE, vol. 8, no. 12, Article ID e81772, 2013.
84. B. Wang, Q. Ni, X. Wang, and L. Lin, "Meta-analysis of the clinical effect of ligustrazine on diabetic nephropathy," The American Journal of Chinese Medicine, vol. 40, no. 1, pp. 25-37, 2012.
85. M. Zhang, L. Feng, J. Gu et al., "The attenuation of Moutan cortex on oxidative stress for renal injury in AGEs-induced mesangial cell dysfunctionand streptozotocin-induceddiabetic nephropathy rats," Oxidative Medicine and Cellular Longevity, vol. 2014, Article ID463815, 13 pages, 2014.
86. M.-H. Zhang, L. Feng, J.-F. Gu, J. Jiang, and X.-B. Jia, "Effect of Moutan Cortex on AGEs-induced mesangial cell proliferation and basement membrane thickening," Zhongguo zhongyao zazhi, vol. 39, no. 3, pp. 478-482, 2014.
87. M.-H. Zhang, L. Feng, M.-M. Zhu et al., "The anti-inflammation effect of Moutan Cortex on advanced glycation end products-induced rat mesangial cells dysfunction and Highglucose-fat diet and streptozotocin-induced diabetic nephropathy rats," Journal of Ethnopharmacology, vol. 151, no. 1, pp. 591-600, 2014.
88. T. Yokozawa, N. Yamabe, H. Y. Kim et al., "Protective effects of morroniside isolated from corni fructus against renal damage in streptozotocin-induced diabetic rats," Biological & Pharmaceutical Bulletin, vol. 31, no. 7, pp. 1422-1428, 2008.
89. Q.-N. Tu, H. Dong, and F.-E. Lu, "Effects of panax notoginoside on the nephropathy in rats with type 1 diabetes mellitus," Chinese Journal of Integrative Medicine, vol. 17, no. 8, pp. 612-615, 2011.
90. Q. Tu, J. Qin, H. Dong, F. Lu, and W. Guan, "Effects of Panax notoginoside on the expression of TGF-beta1 and Smad-7 in renal tissues of diabetic rats," Journal of Huazhong University of Science and Technology-Medical Science, vol. 31, no. 2, pp. 190-193, 2011.
91. Q.-X. Li, H.-J. Zhong, H.-R. Gong et al., "Effect of compound Puerarin on the collage IV in streptozotocin-induced diabetic nephropathy rats," Chinese Journal of Preventive Medicine, vol. 42, no. 4, pp. 254-259, 2008.
92. Y. Zhong, X. Zhang, X. Cai, K. Wang, Y. Chen, and Y. Deng, "Puerarin attenuated early diabetic kidney injury through down-regulation of matrix metalloproteinase 9 in streptozotocin-induced diabetic rats," PLoS ONE, vol. 9, no. 1, Article ID e85690, 2014.
93. Y. Zhang, H. Wang, L. Yu, and J. Chen, "The Puerarin improves renal function in STZ-induced diabetic rats by attenuating eNOS expression," Renal Failure, vol. 37, no. 4, pp. 699-703, 2015.
94. Q. Gao, W.-S. Qin, Z.-H. Jia et al., "Rhein improves renal lesion and ameliorates dyslipidemia in db/db mice with diabetic nephropathy," Planta Medica, vol. 76, no. 1, pp. 27-33, 2010.
95. D.-Q. Yu, Y. Gao, and X.-H. Liu, "Effects of Rhein on the hypertrophy of renal proximal tubular epithelial cells induced by high glucose and angiotensin II in rats," Journal of Chinese Medicinal Materials, vol. 33, no. 4, pp. 570-574, 2010.
96. Z.-S. Wang, F. Gao, and F.-E. Lu, "Effect of ethanol extract of Rhodiola rosea on the early nephropathy in type 2 diabetic rats," Journal of Huazhong University of Science and Technology-Medical Science, vol. 33, no. 3, pp. 375-378, 2013.
97. Y. Zhou, Q. Liao, Y. Luo, Z. Qing, Q. Zhang, and G. He, "Renal protective effect of Rosa laevigata Michx. by the inhibition of oxidative stress in streptozotocin-induced diabetic rats," Molecular Medicine Reports, vol. 5, no. 6, pp. 1548-1554, 2012.
98. X.-W. Li, Y. Liu, W. Hao, and J.-R. Yang, "Sequoyitol ameliorates diabetic nephropathy in diabetic rats induced with a high-fat diet and a low dose of streptozotocin," Canadian Journal of Physiology and Pharmacology, vol. 92, no. 5, pp. 405-417, 2014.
99. H.-W. Chen, S.-L. Wang, and X.-Y. Chen, "Preliminary study on effects of sodium ferulate in treating diabetic nephropathy," Zhongguo Zhongxiyi Jiehe Zazhi, vol. 26, no. 9, pp. 803-806, 2006.
100. S. Zhang, J. Yang, H. Li et al., "Skimmin, a coumarin, suppresses the streptozotocin-induced diabetic nephropathy in wistar rats," European Journal of Pharmacology, vol. 692, no. 1-3, pp. 78-83, 2012.
101. G. Liu, G.-J. Guan, T.-G. Qi et al., "Protective effects of Salvia miltiorrhiza on rats with streptozotocin diabetes and itsmechanism," Journal of Chinese Integrative Medicine, vol. 3, no. 6, pp. 459-462, 2005.
102. S.-H. Lee, Y.-S. Kim, S.-J. Lee, and B.-C. Lee, "The protective effect of Salvia miltiorrhiza in an animal model of early experimentally induced diabetic nephropathy," Journal of Ethnopharmacology, vol. 137, no. 3, pp. 1409-1414, 2011.
103. D. Yin, J. Yin, Y. Yang, S. Chen, and X. Gao, "Renoprotection of Danshen Injection on streptozotocin-induced diabetic rats, associated with tubular function and structure," Journal of Ethnopharmacology, vol. 151, no. 1, pp. 667-674, 2014.
104. J. Su, P. Zhang, J.-J. Zhang, X.-M. Qi, Y.-G. Wu, and J.-J. Shen, "Effects of total glucosides of paeony on oxidative stress in the kidney from diabetic rats," Phytomedicine, vol. 17, no. 3-4, pp. 254-260, 2010.
105. B. C. Chang, W. D. Chen, Y. Zhang, P. Yang, L. Liu, and J. Wang, "Effect of total glucosides of paeony on Wnt/beta-catenin signal transduction pathway expression in kidney of diabetic rats," Zhongguo Zhongyao Zazhi, vol. 39, no. 19, pp. 3829-3835, 2014.
106. Q.-H. Yang, Y. Liang, Q. Xu, Y. Zhang, L. Xiao, and L.-Y. Si, "Protective effect of tetramethylpyrazine isolated from Ligusticum chuanxiong on nephropathy in rats with streptozotocin-induced diabetes," Phytomedicine, vol. 18, no. 13, pp. 1148-1152, 2011.
107. Q. Gao, W. Shen, W. Qin et al., "Treatment of db/db diabetic mice with triptolide: a novel therapy for diabetic nephropathy," Nephrology Dialysis Transplantation, vol. 25, no. 11, pp. 3539-3547, 2010.
108. R.-X. Ma, N. Zhao, and W. Zhang, "The effects andmechanism of Tripterygium wilfordii Hook F combination with irbesartan on urinary podocyte excretion in diabetic nephropathy patients," Zhonghua Nei Ke Za Zhi, vol. 52, no. 6, pp. 469-473, 2013.
109. X.-P. Sun, N.-S. Wang, Q. Xue, and F. Wang, "Volatile oil of Magnolia biondii inhibits expressions of P-selectin protein in serum and renal tissue of rats with diabetic nephropathy," Journal of Chinese Integrative Medicine, vol. 6, no. 5, pp. 524-529, 2008.
110. H.-W. Gu, Z.-H. Ni, L.-Y. Gu et al., "Effects of Astragalus on expression of renal angiopoietin receptor Tie-2 in diabetic rats," Journal of Chinese Integrative Medicine, vol. 5, no. 5, pp. 536-540, 2007.
111. D. Tang, B. He, Z.-G. Zheng et al., "Inhibitory effects of two major isoflavonoids in Radix Astragali on high glucose-induced mesangial cells proliferation and AGEs-induced endothelial cells apoptosis," Planta Medica, vol. 77, no. 7, pp. 729-732, 2011.
112. K. Agyemang, L. Han, E. Liu, Y. Zhang, T. Wang, and X. Gao, "Recent advances in Astragalus membranaceus antidiabetic research: pharmacological effects of its phytochemical constituents," Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 654643, 9 pages, 2013.
113. Q. Wang, X. Shao, W. Xu et al., "Astragalosides IV inhibits high glucose-induced cell apoptosis through HGF activation in cultured human tubular epithelial cells," Renal Failure, vol. 36, no. 3, pp. 400-406, 2014.
114. W. Wu, H. Geng, Z. Liu, H. Li, and Z. Zhu, "Effect of curcumin on rats/mice with diabetic nephropathy: a systematic review and meta-analysis of randomized controlled trials," Journal of Traditional Chinese Medicine, vol. 34, no. 4, pp. 419-429, 2014.
115. Q. Sun, G. Yang, M. Zhang, M. Zhang, S. Chen, and P. Chen, "Effect of Huangshukuihua (Flos Abelmoschi Manihot) on diabetic nephropathy: a meta-analysis," Journal of Traditional Chinese Medicine, vol. 35, no. 1, pp. 15-20, 2015.
116. N. Yamabe, K. S. Kang, E. Goto, T. Tanaka, and T. Yokozawa, "Beneficial effect of Corni Fructus, a constituent of Hachimijio-gan, on advanced glycation end-product-mediated renal injury in streptozotocin-treated diabetic rats," Biological & Pharmaceutical Bulletin, vol. 30, no. 3, pp. 520-526, 2007.
117. W. Ma, K.-J. Wang, C.-S. Cheng et al., "Bioactive compounds from Cornus officinalis fruits and their effects on diabetic nephropathy," Journal of Ethnopharmacology, vol. 153, no. 3, pp. 840-845, 2014.
118. X. Ma, X. Xie, C. Zuo, and J. Fan, "Effects of ginsenoside Rg1 on streptozocin-induced diabetic nephropathy in rats," Journal of Biomedical Engineering, vol. 27, no. 2, pp. 342-347, 2010.
119. N. Mao, Y. Cheng, X.-L. Shi et al., "Ginsenoside Rg1 protects mouse podocytes from aldosterone-induced injury in vitro," Acta Pharmacologica Sinica, vol. 35, no. 4, pp. 513-522, 2014.
120. T. Yokozawa, H. Y. Kim, and N. Yamabe, "Amelioration of diabetic nephropathy by dried Rehmanniae Radix (Di Huang) extract," The American Journal of Chinese Medicine, vol. 32, no. 6, pp. 829-839, 2004.
121. Z. Dong and C. X. Chen, "Effect of catalpol on diabetic nephropathy in rats," Phytomedicine, vol. 20, no. 11, pp. 1023-1029, 2013.
122. H. Yin, X. Yan, and K. H. Yang, "Systematic review on sodium ferulate for treatment of diabetic nephropathy," Zhongguo Zhongxiyi Jiehe Zazhi, vol. 29, no. 11, pp. 970-974, 2009.
123. H. Zhang, W. Sun, Y. Wan et al., "Preventive effects of multi-glycoside of Tripterygium wilfordii on glomerular lesions in experimental diabetic nephropathy," Zhongguo Zhongyao Zazhi, vol. 35, no. 11, pp. 1460-1465, 2010.
124. J.-P. Li, X.-L. He, and Q. Li, "Clinical study on treatment of early diabetic nephropathy by tangshenling combined with telmisartan," Chinese Journal of Integrated Traditional and Western Medicine, vol. 26, no. 5, pp. 415-418, 2006.
125. X.-L. He, J.-P. Li, Y.-P. Chen, Z.-G. Zhang, W.-Q. Lin, and J.-H. Chen, "Effects of Tangshenling Mixture and benazepril on rats with diabetic nephropathy and its mechanism," Journal of Chinese Integrative Medicine, vol. 4, no. 1, pp. 43-47, 2006.
126. H.-X. Song, J. Gong, and W. Chen, "Effect of triptolide on urinary monocyte chemottractant protein-1 in patients with diabetic nephropathy," Chinese Journal of Integrated Traditional and Western Medicine, vol. 25, no. 5, pp. 416-418, 2005.
127. J. Song, Y. H. Li, and X. D. Yang, "Effect of combined therapy with bailing capsule and benazepril on urinary albumin excretion rate and C-reactive protein in patients with early diabetic nephropathy," Chinese Journal of Integrated Traditional and Western Medicine, vol. 29, no. 9, pp. 791-793, 2009.
128. D.-Z. Guo, Y.-H. Wang, and Z.-Q. Chen, "Effect of treatment in 39 patients with diabetic nephropathy by safflor yellow and benazepril in combination," Chinese Journal of Integrated Traditional and Western Medicine, vol. 28, no. 4, pp. 360-363, 2008.
129. L. Zhao, L.-G. Lan, X.-L. Min et al., "Integrated treatment of traditional Chinese medicine and western medicine for early- and intermediate-stage diabetic nephropathy," Journal of Southern Medical University, vol. 27, no. 7, pp. 1052-1055, 2007.